TWD
RCEL icon

True Wealth Design’s Avita Medical RCEL Stock Holding History

True Wealth Design’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$608 Buy
147
+138
+1,533% +$595 ﹤0.01% 2133
2026
Q1 		$34 Buy
9
+7
+350% +$29 ﹤0.01% 2595
2025
Q4 		$7 Sell
2
-2
-50% -$8 ﹤0.01% 2540
2025
Q3 		$21 Buy
+4
New +$21 ﹤0.01% 2657
2025
Q2 		– Sell
-109
Closed -$888 – 2780
2025
Q1 		$888 Buy
+109
New +$1.02K ﹤0.01% 1307

Other funds holding RCEL

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

True Wealth Design's RCEL Position: Q2 2026 in Review

True Wealth Design increased its Avita Medical (RCEL) stake by 1,533% in Q2 2026, buying an estimated $595 and bringing the position to 147 shares worth $608. The position accounts for ﹤0.01% of the portfolio, ranked #2133.

True Wealth Design first reported a position in RCEL in Q1 2025 and has held it in 5 quarters since. The position peaked at $888 in Q1 2025. 73 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • True Wealth Design held 147 shares of Avita Medical worth $608 as of Q2 2026.
  • True Wealth Design bought 138 Avita Medical shares in Q2 2026, an estimated $595.
  • Avita Medical made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #2133 holding.
  • True Wealth Design first reported a position in Avita Medical in Q1 2025 and has held it in 5 quarters since.
  • True Wealth Design's Avita Medical position peaked at $888 in Q1 2025.
  • 73 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.